Table 1.
Baseline demographic and glaucoma status
| Patients | KDB-Alone | KBD-Phaco | P |
|---|---|---|---|
| n=39 | n=51 | ||
| Age (years), mean ± SD | 79.9±7.2 | 74.6±6.0 | <0.001 |
| Gender, n (%) | |||
| Female | 22 (56%) | 21 (41%) | 0.151 |
| Male | 17 (44%) | 30 (59%) | |
| Anticoagulation therapy, n (%) | 17 (44%) | 15 (29%) | 0.164 |
| Glaucoma type, n (%) | |||
| POAG | 14 (36%) | 20 (39%) | 0.748 |
| PEXG | 25 (64%) | 31 (61%) | |
| Glaucoma stage, n (%) | |||
| <6 dB | 2 (5%) | 12 (23.5%) | 0.523 |
| 6–12 dB | 12 (31%) | 12 (23.5%) | |
| >12 dB | 21 (54%) | 24 (47%) | |
| Undetermined | 4 (10%) | 3 (6%) | |
| BCVA logMAR, mean ± SD | 0.29±0.24 | 0.25±0.30 | 0.479 |
| Previous glaucoma surgery or TCP, n (%) | 8 (21%) | 1 (2%) | 0.004 |
Abbreviations: BCVA, best-corrected visual acuity; logMAR, logarithm of the minimum angle of resolution; PEXG, pseudoexfoliation glaucoma; POAG, primary open-angle glaucoma; TCP, transscleral cyclophotocoagulation.